JADE BIOSCIENCES, INC. (JBIO)
Jade Biosciences Announces Proposed Underwritten Public Offering
Jade Biosciences Announces Proposed Underwritten Public Offering
Alignment Healthcare Named to the Fortune 1000 2026 List for Second Consecutive Year
IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
Verastem Oncology Announces U.S. FDA Fast Track Designation for VS-7375, an Oral and Potential Best-in-Class Investigational KRAS G12D (ON/OFF) Inhibitor for the Treatment of KRAS G12D-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Vertex to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 10
Albany Engineered Composites to Showcase Advanced Composite Technologies at the Farnborough International Airshow 2026
Intuit CFO Sandeep Aujla to Present at the Nasdaq Investor Conference
Walmart Grants $10.8M to Matthew 25: Ministries for Disaster Fleet Expansion in Collaboration with Procter & Gamble
Photronics to Participate in Upcoming Investor Conferences